Global spinal biologics market to reach $2.55B by 2024 — 3 insights

Written by Shayna Korol | March 26, 2019 | Print  |

The global spinal biologics market is projected to grow at a 3.6 percent compound annual growth rate to reach $2.55 billion by 2024, according to a Market Study Report.

Three things to know about the global spinal biologics market:

1. North America is the largest supplier of spinal biologics, with a production market share of nearly 63 percent.

2. Europe is the second-largest spinal biologics supplier, with a production market share of nearly 28 percent.

2. Market competition is not intense, according to the report. Medtronic, DePuy Synthes, Stryker, NuVasive and Zimmer Biomet are the key market players; in 2015, Medtronic had a 40 percent market share.

More articles on spine surgery: 
The spine surgery devices, techniques that won't stand the test of time
How spine surgeons view consolidation in healthcare
4 spine, neurosurgeons on the move in February

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months